Keywords: Carbon Disulfide Hydrolase, Carbonic Anhydrase, Carbonyl Sulfide Hydrolase, Coumarin, Dithiocarbamate, Ester, Hydroxamate, Natural Product, Phenol, Polyamine, Sulfocoumarin, Sulfonamide, X-Ray Crystallography, Benzenesulfonohydroxamic Acid, Carbon Dioxide, Carbonate Dehydratase Iii, Carbonate Dehydratase Inhibitor, Carbonate Dehydratase Xii, Hydroxamic Acid Derivative, N Methoxybenzenesulfonamide, Unclassified Drug, Binding Site, Catalysis, Chemical Structure, Drug Design, Drug Structure, Enzyme Inhibition, Hydrophilicity, Hydrophobicity, Priority Journal, Review, X Ray Crystallography, Carbonic Anhydrase Inhibitors, Humans, Hydrophobic And Hydrophilic Interactions, Models, Molecular, Structure-Activity Relationship,
Affiliations: *** IBB - CNR ***
Istituto di Biostrutture e Bioimmagini-CNR, via Mezzocannone 16, 80134 Naples, Italy
Università Degli Studi di Firenze, NEUROFARBA Department, Via Ugo Schiff 6, 50019 Sesto Fiorentino (Florence), Italy
Universit Degli Studi di Firenze, NEUROFARBA Department, Via Ugo Schiff 6, 50019 Sesto Fiorentino (Florence), Italy
References: Alterio, V., Di Fiore, A., D'Ambrosio, K., Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? (2012) Chem Rev, 112, pp. 4421-446
Smeulders, M.J., Barends, T.R., Pol, A., Evolution of a new enzyme for carbon disulphide conversion by an acidothermophilic archaeon (2011) Nature, 478, pp. 412-416
Ogawa, T., Noguchi, K., Saito, M., Carbonyl sulfide hydrolase from Thiobacillus thioparus strain THI115 is one of the b-carbonic anhydrase family enzymes (2013) J Am Chem Soc, 135, pp. 3818-3825
Supuran, C.T., Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators (2008) Nat Rev Drug Discov, 7, pp. 168-181
Smith, K.S., Jakubzick, C., Whittam, T.S., Ferry, J.G., Carbonic anhydrase is an ancient enzyme widespread in prokaryotes (1999) Proc Natl Acad Sci USA, 96, pp. 15184-15189
Xu, Y., Feng, L., Jeffrey, P.D., Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms (2008) Nature, 452, pp. 56-61
Neri, D., Supuran, C.T., Interfering with pH regulation in tumours as a therapeutic strategy (2011) Nat Rev Drug Discov, 10, pp. 767-777
Eriksson, A.E., Jones, T.A., Liljas, A., Refined structure of human carbonic anhydrase II at 2.0 A resolution (1988) Proteins, 4, pp. 274-282
Supuran, C.T., Bacterial carbonic anhydrases as drug targets: Towards novel antibiotics? (2011) Front Pharmacol, 2, p. 34
Bertucci, A., Moya, A., Tambutté, S., Carbonic anhydrases in anthozoan corals-A review (2013) Bioorg Med Chem, 21, pp. 1437-1450
Monti, S.M., De Simone, G., Dathan, N.A., Kinetic and anion inhibition studies of a beta-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis (2013) Bioorg Med Chem Lett, 23, pp. 1626-1630
Alterio, V., Langella, E., Viparelli, F., Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii (2012) Biochimie, 94, pp. 1232-1241
Supuran, C.T., Scozzafava, A., Casini, A., Carbonic anhydrase inhibitors (2003) Med Res Rev, 23, pp. 146-189
Aggarwal, M., McKenna, R., Update on carbonic anhydrase inhibitors: A patent review 2008-2011) (2012) Expert Opin Ther Pat, 22, pp. 903-915
De Simone, G., Supuran, C.T., (In)organic anions as carbonic anhydrase inhibitors (2012) J Inorg Biochem, 111, pp. 117-129
Supuran, C.T., Structure-based drug discovery of carbonic anhydrase inhibitors (2012) J Enzyme Inhib Med Chem, 27, pp. 759-772
Covarrubias, A.S., Bergfors, T., Jones, T.A., Hogbom, M., Structural mechanics of the pH-dependent activity of the beta-carbonic anhydrase from Mycobacterium tuberculosis (2006) J Biol Chem, 281, pp. 4993-4999
Schlicker, C., Hall, R.A., Vullo, D., Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans (2009) J Mol Biol, 385, pp. 1207-1220
Pacchiano, F., Carta, F., Vullo, D., Inhibition of beta-carbonic anhydrases with ureido-substituted benzenesulfonamides (2010) Bioorg Med Chem Lett, 20, pp. 102-105
Domsic, J.F., Avvaru, B.S., Kim, C.U., Entrapment of carbon dioxide in the active site of carbonic anhydrase II (2008) J Biol Chem, 283, pp. 30766-30771
Briganti, F., Mangani, S., Orioli, P., Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes i and II with histamine (1997) Biochemistry, 36, pp. 10384-10392
Temperini, C., Scozzafava, A., Vullo, D., Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII and XIV with L-and D-histidine and crystallographic analysis of their adducts with isoform II: Engineering proton transfer processes within the active site of an enzyme (2006) Chemistry (Easton), 12, pp. 7057-7066
Maupin, C.M., Castillo, N., Taraphder, S., Chemical rescue of enzymes: Proton transfer in mutants of human carbonic anhydrase II (2011) J Am Chem Soc, 133, pp. 6223-6234
Alterio, V., Hilvo, M., Di Fiore, A., Crystal structure of the extracellular catalytic domain of the tumor-associated human carbonic anhydrase IX (2009) Proc Natl Acad Sci USA, 106, pp. 16233-16238
Di Fiore, A., Monti, S.M., Hilvo, M., Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide (2009) Proteins, 74, pp. 164-175
Di Fiore, A., Truppo, E., Supuran, C.T., Crystal structure of the C183S/C217S mutant of human CA VII in complex with acetazolamide (2010) Bioorg Med Chem Lett, 20, pp. 5023-5026
Whittington, D.A., Waheed, A., Ulmasov, B., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc Natl Acad Sci USA, 98, pp. 9545-9550
Aggarwal, M., Boone, C.D., Kondeti, B., McKenna, R., Structural annotation of human carbonic anhydrases (2013) J Enzyme Inhib Med Chem, 28, pp. 267-277
Liljas, A., Kannan, K.K., Bergstén, P.C., Crystal structure of human carbonic anhydrase C (1972) Nat New Biol, 235, pp. 131-137
Peña, K.L., Castel, S.E., De Araujo, C., Structural basis of the oxidative activation of the carboxysomal g-carbonic anhydrase, CcmM (2010) Proc Natl Acad Sci USA, 107, pp. 2455-2460
Weber, A., Casini, A., Heine, A., Unexpected nanomolar inhibition of carbonic anhydrase by COX-2 selective celecoxib: New pharmacological opportunities due to related binding site recognition (2004) J Med Chem, 47, pp. 550-557
Di Fiore, A., Pedone, C., D'Ambrosio, K., Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib (2006) Bioorg Med Chem Lett, 16, pp. 437-442
Kohler, K., Hillebrecht, A., Schulze Wischeler, J., Saccharin inhibits carbonic anhydrases: Possible explanation for its unpleasant metallic aftertaste (2007) Angew Chem Int Ed Engl, 46, pp. 7697-7699
Hilvo, M., Innocenti, A., Monti, S.M., Recent advances in research on the most novel carbonic anhydrases, CA XIII and XV (2008) Curr Pharm des, 14, pp. 672-678
Woo, L.W., Ganeshapillai, D., Thomas, M.P., Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495) (2011) ChemMedChem, 6, pp. 2019-2034
Kolayli, S., Karahalil, F., Sahin, H., Characterization and inhibition studies of an a-carbonic anhydrase from the endangered sturgeon species Acipenser gueldenstaedti (2011) J Enzyme Inhib Med Chem, 26, pp. 895-900
Carta, F., Aggarwal, M., Maresca, A., Dithiocarbamates: A new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations (2012) Chem Commun (Camb), 48, pp. 1868-1870
Maresca, A., Carta, F., Vullo, D., Supuran, C.T., Dithiocarbamates strongly inhibit the beta-class carbonic anhydrases from Mycobacterium tuberculosis (2013) J Enzyme Inhib Med Chem, 28, pp. 407-411
Pan, P., Vermelho, A.B., Capaci Rodrigues, G., Cloning, characterization, and sulfonamide and thiol inhibition studies of an alpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease (2013) J Med Chem, 56, pp. 1761-1771
Almajan, G.L., Innocenti, A., Puccetti, L., Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1, 3, 4-thiadiazole-and 1, 2, 4-triazole-thiols (2005) Bioorg Med Chem Lett, 15, pp. 2347-2352
Di Fiore, A., Maresca, A., Supuran, C.T., De Simone, G., Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors (2012) Chem Commun (Camb), 48, pp. 8838-8840
Scozzafava, A., Supuran, C.T., Carbonic anhydrase and matrix metalloproteinase inhibitors: Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes (2000) J Med Chem, 43, pp. 3677-3687
Nair, S.K., Ludwig, P.A., Christianson, D.W., Two-site binding of phenol in the active site of human carbonic anhydrase II: Structural implications for substrate association (1994) J Am Chem Soc, 116, pp. 3659-3660
Davis, R.A., Innocenti, A., Poulsen, S.A., Supuran, C.T., Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes i and II from a natural product-based phenolic library (2010) Bioorg Med Chem, 18, pp. 14-18
Martin, D.P., Cohen, S.M., Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors (2012) Chem Commun (Camb), 48, pp. 5259-5261
Carta, F., Temperini, C., Innocenti, A., Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule (2010) J Med Chem, 53, pp. 5511-5522
Davis, R.A., Hofmann, A., Osman, A., Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases (2011) J Med Chem, 54, pp. 1682-1692
Tars, K., Vullo, D., Kazaks, A., Sulfocoumarins (1, 2-benzoxathiine-2, 2-dioxides): A class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases (2013) J Med Chem, 56, pp. 293-300
Maresca, A., Temperini, C., Vu, H., Non-zinc mediated inhibition of carbonic anhydrases: Coumarins are a new class of suicide inhibitors (2009) J Am Chem Soc, 131, pp. 3057-3062
Touisni, N., Maresca, A., McDonald, P.C., Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors (2011) J Med Chem, 54, pp. 8271-8277
McDonald, P.C., Winum, J.Y., Supuran, C.T., Dedhar, S., Recent developments in targeting carbonic anhydrase IX for cancer therapeutics (2012) Oncotarget, 3, pp. 84-97
Davis, R.A., Vullo, D., Maresca, A., Natural product coumarins that inhibit human carbonic anhydrases (2013) Bioorg Med Chem, 21, pp. 1539-1543
Simonsson, I., Jonsson, B.H., Lindskog, S., Phenol, a competitive inhibitor of CO2 hydration catalyzed by carbonic anhydrase (1982) Biochem Biophys Res Commun, 108, pp. 1406-1412
Buchieri, M.V., Riafrecha, L.E., Rodríguez, O.M., Inhibition of the b-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: Identification of the first inhibitor with anti-mycobacterial activity (2013) Bioorg Med Chem Lett, 23, pp. 740-743
Ekinci, D., Karagoz, L., Ekinci, D., Carbonic anhydrase inhibitors: In vitro inhibition of a isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids (2013) J Enzyme Inhib Med Chem, 28, pp. 283-288
Sahin, H., Can, Z., Yildiz, O., Inhibition of carbonic anhydrase isozymes i and II with natural products extracted from plants, mushrooms and honey (2012) J Enzyme Inhib Med Chem, 27, pp. 395-402
Lopez, M., Vu, H., Wang, C.K., Promiscuity of carbonic anhydrase II. Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors (2011) J Am Chem Soc, 133, pp. 18452-18462
Kazancioǧlu, E.A., Güney, M., Şentürk, M., Supuran, C.T., Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity (2012) J Enzyme Inhib Med Chem, 27, pp. 880-885
Innocenti, A., Supuran, C.T., Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of a-but not of b-, g-and z-carbonic anhydrases (2010) Bioorg Med Chem Lett, 20, pp. 6208-6212
Innocenti, A., Scozzafava, A., Parkkila, S., Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates (2008) Bioorg Med Chem Lett, 18, pp. 2267-2271
Cavdar, H., Ekinci, D., Talaz, O., A-Carbonic anhydrases are sulfatases with cyclic diol monosulfate esters (2012) J Enzyme Inhib Med Chem, 27, pp. 148-154
Carta, F., Maresca, A., Scozzafava, A., Supuran, C.T., 5-and 6-membered (thio) lactones are prodrug type carbonic anhydrase inhibitors (2012) Bioorg Med Chem Lett, 22, pp. 267-270
Huang, S., Hainzl, T., Grundstrom, C., Structural studies of beta-carbonic anhydrase from the green alga Coccomyxa: Inhibitor complexes with anions and acetazolamide (2011) PLoS ONE, 6, pp. e28458
Casini, A., Scozzafava, A., Mincione, F., Carbonic anhydrase inhibitors: Water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects (2000) J Med Chem, 43, pp. 4884-4892
Scozzafava, A., Menabuoni, L., Mincione, F., Supuran, C.T., Carbonic anhydrase inhibitors. A general approach for the preparation of water soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long lasting, topical intraocular pressure lowering properties (2002) J Med Chem, 45, pp. 1466-1476
Fabrizi, F., Mincione, F., Somma, T., A new approach to antiglaucoma drugs: Carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology (2012) J Enzyme Inhib Med Chem, 27, pp. 138-147
Svastová, E., Hulíková, A., Rafajová, M., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Ahlskog, J.K.J., Dumelin, C.E., Trüssel, S., In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives (2009) Bioorg Med Chem Lett, 19, pp. 4851-4856
Lou, Y., McDonald, P.C., Oloumi, A., Targeting tumor hypoxia: Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors (2011) Cancer Res, 71, pp. 3364-3376
Carta, F., Supuran, C.T., Scozzafava, A., Novel therapies for glaucoma: A patent review 2007-2011 (2012) Expert Opin Ther Pat, 22, pp. 79-88
Steele, R.M., Benedini, F., Biondi, S., Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma (2009) Bioorg Med Chem Lett, 19, pp. 6565-6570
Mincione, F., Benedini, F., Biondi, S., Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action (2011) Bioorg Med Chem Lett, 21, pp. 3216-3221
Alterio, V., Vitale, R.M., Monti, S.M., Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX (2006) J Am Chem Soc, 128, pp. 8329-8335
Alterio, V., De Simone, G., Monti, S.M., Carbonic anhydrase inhibitors: Inhibition of human, bacterial, and archaeal isozymes with benzene-1, 3-disulfonamides-Solution and crystallographic studies (2007) Bioorg Med Chem Lett, 17, pp. 4201-4207
Wagner, J., Avvaru, B.S., Robbins, A.H., Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: Solution and crystallographic investigations (2010) Bioorg Med Chem, 18, pp. 4873-4878
Biswas, S., Aggarwal, M., Guzel, O., Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms (2011) Bioorg Med Chem, 19, pp. 3732-3738
Pacchiano, F., Aggarwal, M., Avvaru, B.S., Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido- benzenesulfonamides and correlate to inhibitor potency (2010) Chem Commun (Camb), 46, pp. 8371-8373
Carta, F., Garaj, V., Maresca, A., Sulfonamides incorporating 1, 3, 5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms i and II: Solution and X-ray crystallographic studies (2011) Bioorg Med Chem, 19, pp. 3105-3119
Hen, N., Bialer, M., Yagen, B., Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII and XIV (2011) J Med Chem, 54, pp. 3977-81
Güzel, O., Innocenti, A., Scozzafava, A., Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl-and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors (2009) Bioorg Med Chem Lett, 19, pp. 3170-3173
Garaj, V., Puccetti, L., Fasolis, G., Carbonic anhydrase inhibitors: Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II and IX with sulfonamides incorporating 1, 2, 4-triazine moieties (2004) Bioorg Med Chem Lett, 14, pp. 5427-5433
Pastorekova, S., Parkkila, S., Pastorek, J., Supuran, C.T., Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects (2004) J Enzyme Inhib Med Chem, 19, pp. 199-229
Zimmerman, S., Innocenti, A., Casini, A., Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides (2004) Bioorg Med Chem Lett, 14, pp. 6001-6006
Jude, K.M., Banerjee, A.L., Haldar, M.K., Ultrahigh resolution crystal structures of human carbonic anhydrases i and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity (2006) J Am Chem Soc, 128, pp. 3011-3018
Kim, C.Y., Chandra, P.P., Jain, A., Christianson, D.W., Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II (2001) J Am Chem Soc, 123, pp. 9620-9627
De Simone, G., Vitale, R.M., Di Fiore, A., Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX (2006) J Med Chem, 49, pp. 5544-5551
Avvaru, B.S., Wagner, J.M., Maresca, A., Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors (2010) Bioorg Med Chem Lett, 20, pp. 4376-4381
Biswas, S., Carta, F., Scozzafava, A., Structural effect of phenyl ring compared to thiadiazole based adamantyl-sulfonamides on carbonic anhydrase inhibition (2013) Bioorg Med Chem, 21, pp. 2314-2318
Whittaker, M., Floyd, C.D., Brown, P., Gearing, A.J.H., Design and therapeutic application of matrix metalloproteinase inhibitors (1999) Chem Rev, 99, pp. 2735-2776
Scolnick, L.R., Clements, A.M., Liao, J., Novel binding mode of hydroxamate inhibitors to human carbonic anhydrase II (1997) J Am Chem Soc, 119, pp. 850-851
Fisher, S.Z., Aggarwal, M., Kovalevsky, A.Y., Neutron diffraction of acetazolamide-bound human carbonic anhydrase II reveals atomic details of drug binding (2012) J Am Chem Soc, 134, pp. 14726-14729
Capasso, C., Supuran, C.T., Anti-infective carbonic anhydrase inhibitors: A patent and literature review (2013) Expert Opin Ther Pat, , published online 14 March 2013
doi:10.1517/13543776.2013.778245
Smeulders, M. J., Barends, T. R., Pol, A., Evolution of a new enzyme for carbon disulphide conversion by an acidothermophilic archaeon (2011) Nature, 478, pp. 412-416
Supuran, C. T., Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators (2008) Nat Rev Drug Discov, 7, pp. 168-181
Smith, K. S., Jakubzick, C., Whittam, T. S., Ferry, J. G., Carbonic anhydrase is an ancient enzyme widespread in prokaryotes (1999) Proc Natl Acad Sci USA, 96, pp. 15184-15189
Eriksson, A. E., Jones, T. A., Liljas, A., Refined structure of human carbonic anhydrase II at 2. 0 A resolution (1988) Proteins, 4, pp. 274-282
Supuran, C. T., Bacterial carbonic anhydrases as drug targets: Towards novel antibiotics? (2011) Front Pharmacol, 2, p. 34
Monti, S. M., De Simone, G., Dathan, N. A., Kinetic and anion inhibition studies of a beta-carbonic anhydrase (FbiCA 1) from the C4 plant Flaveria bidentis (2013) Bioorg Med Chem Lett, 23, pp. 1626-1630
Supuran, C. T., Scozzafava, A., Casini, A., Carbonic anhydrase inhibitors (2003) Med Res Rev, 23, pp. 146-189
Supuran, C. T., Structure-based drug discovery of carbonic anhydrase inhibitors (2012) J Enzyme Inhib Med Chem, 27, pp. 759-772
Covarrubias, A. S., Bergfors, T., Jones, T. A., Hogbom, M., Structural mechanics of the pH-dependent activity of the beta-carbonic anhydrase from Mycobacterium tuberculosis (2006) J Biol Chem, 281, pp. 4993-4999
Domsic, J. F., Avvaru, B. S., Kim, C. U., Entrapment of carbon dioxide in the active site of carbonic anhydrase II (2008) J Biol Chem, 283, pp. 30766-30771
Maupin, C. M., Castillo, N., Taraphder, S., Chemical rescue of enzymes: Proton transfer in mutants of human carbonic anhydrase II (2011) J Am Chem Soc, 133, pp. 6223-6234
Whittington, D. A., Waheed, A., Ulmasov, B., Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells (2001) Proc Natl Acad Sci USA, 98, pp. 9545-9550
Pe a, K. L., Castel, S. E., De Araujo, C., Structural basis of the oxidative activation of the carboxysomal g-carbonic anhydrase, CcmM (2010) Proc Natl Acad Sci USA, 107, pp. 2455-2460
Woo, L. W., Ganeshapillai, D., Thomas, M. P., Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495) (2011) ChemMedChem, 6, pp. 2019-2034
Almajan, G. L., Innocenti, A., Puccetti, L., Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1, 3, 4-thiadiazole-and 1, 2, 4-triazole-thiols (2005) Bioorg Med Chem Lett, 15, pp. 2347-2352
Nair, S. K., Ludwig, P. A., Christianson, D. W., Two-site binding of phenol in the active site of human carbonic anhydrase II: Structural implications for substrate association (1994) J Am Chem Soc, 116, pp. 3659-3660
Davis, R. A., Innocenti, A., Poulsen, S. A., Supuran, C. T., Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes i and II from a natural product-based phenolic library (2010) Bioorg Med Chem, 18, pp. 14-18
Martin, D. P., Cohen, S. M., Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors (2012) Chem Commun (Camb), 48, pp. 5259-5261
Davis, R. A., Hofmann, A., Osman, A., Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases (2011) J Med Chem, 54, pp. 1682-1692
McDonald, P. C., Winum, J. Y., Supuran, C. T., Dedhar, S., Recent developments in targeting carbonic anhydrase IX for cancer therapeutics (2012) Oncotarget, 3, pp. 84-97
Davis, R. A., Vullo, D., Maresca, A., Natural product coumarins that inhibit human carbonic anhydrases (2013) Bioorg Med Chem, 21, pp. 1539-1543
Buchieri, M. V., Riafrecha, L. E., Rodr guez, O. M., Inhibition of the b-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: Identification of the first inhibitor with anti-mycobacterial activity (2013) Bioorg Med Chem Lett, 23, pp. 740-743
Kazancio lu, E. A., G ney, M., ent rk, M., Supuran, C. T., Simple methanesulfonates are hydrolyzed by the sulfatase carbonic anhydrase activity (2012) J Enzyme Inhib Med Chem, 27, pp. 880-885
Svastov, E., Hul kov, A., Rafajov, M., Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH (2004) FEBS Lett, 577, pp. 439-445
Ahlskog, J. K. J., Dumelin, C. E., Tr ssel, S., In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives (2009) Bioorg Med Chem Lett, 19, pp. 4851-4856
Steele, R. M., Benedini, F., Biondi, S., Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma (2009) Bioorg Med Chem Lett, 19, pp. 6565-6570
G zel, O., Innocenti, A., Scozzafava, A., Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl-and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors (2009) Bioorg Med Chem Lett, 19, pp. 3170-3173
Jude, K. M., Banerjee, A. L., Haldar, M. K., Ultrahigh resolution crystal structures of human carbonic anhydrases i and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity (2006) J Am Chem Soc, 128, pp. 3011-3018
Kim, C. Y., Chandra, P. P., Jain, A., Christianson, D. W., Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II (2001) J Am Chem Soc, 123, pp. 9620-9627
Avvaru, B. S., Wagner, J. M., Maresca, A., Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors (2010) Bioorg Med Chem Lett, 20, pp. 4376-4381
Scolnick, L. R., Clements, A. M., Liao, J., Novel binding mode of hydroxamate inhibitors to human carbonic anhydrase II (1997) J Am Chem Soc, 119, pp. 850-851
Fisher, S. Z., Aggarwal, M., Kovalevsky, A. Y., Neutron diffraction of acetazolamide-bound human carbonic anhydrase II reveals atomic details of drug binding (2012) J Am Chem Soc, 134, pp. 14726-14729
doi: 10. 1517/13543776. 2013. 778245
Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors